Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk's Experimental Oral Drug Reports 'Remarkable' Weight Loss, Early Data Shows
In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months. Amycretin targets GLP-1 receptors and a second hormone called amylin. Amylin appears to act in the brain,
Can Novo Nordisk's Weight Loss Drug Ozempic Help Stem The Devastating Addiction Crisis? New Research Says Yes
Patients on semaglutide, the active ingredient in Ozempic and the weight-loss drug Wegovy, were less than half as likely to overdose.
Bernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugs
Sen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes medications, Ozempic and Wegovy.
Novo Nordisk CEO faces US Congress scrutiny over weight-loss drug pricing
U.S. Senator Bernie Sanders is set to question Novo Nordisk CEO Lars Jorgensen on Tuesday over the drugmaker's prices for its popular weight-loss and diabetes medicines that can cost Americans more than $1,
Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side Effects
Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to its trial results, it has some pretty freaky side effects. As Fierce Biotech reports,
In Depth
EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen'
Novo Nordisk under political pressure over high U.S. drug prices as CEO testifies before Congress. PBMs and limited impact on company's bottom line.
Novo Nordisk scolded by UK drug marketing watchdog over sponsorship of weight loss services
Novo Nordisk has earnt yet another dressing down from the PMCPA. The U.K. | Novo Nordisk has earnt yet another dressing down from the PMCPA. The U.K. self-regulatory body found fault with Novo’s support for U.
Braun to Novo Nordisk CEO: “Why are Americans paying more for the same drug?”
On Tuesday, U.S. Senator Mike Braun (R-Ind.) questioned Novo Nordisk CEO Lars Fruergaard Jørgensen at the Senate Health, Education, Labor, and Pensions Committee hearing about the high prices of the company’s weight loss drug,
Novo Nordisk CEO grilled over steep weight loss drug costs
Novo Nordisk CEO Lars Fruergaard Jørgensen testified before the Senate Health, Education, Labor and Pension committee on Tuesday.
Lawmakers press Novo Nordisk CEO over weight-loss drug prices
The Senate Committee on Health, Education, Labor and Pensions held a hearing on Tuesday, to discuss Novo Nordisk lowering prices for weight-loss drugs.
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic
During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its blockbuster drugs Ozempic and Wegovy.
NBC New York
16d
Novo Nordisk weight-loss drug is effective for kids as young as 6, study shows
A
drug
approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with ...
3h
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
1d
on MSN
Ozempic May Decrease Opioid Overdose Risk, Study Suggests: What To Know
Patients taking Ozempic were about 60% less likely to have an opioid overdose compared to those taking other diabetes drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Promotes watch collection
World's oldest cheese found
Producing doc on Diddy
Ending password-sharing
Urgent safety alert for 737s
50/50 ball ownership suit
Boxes to distribute Narcan
US sanctions crypto network
Targeted Black residents?
Stadiums to serve as shelters
Chinese submarine sank
More executives leave
Kotb leaving 'Today'
On Secret Service failures
NC board removes 747K
NIH finds misconduct
WI duplicate ballot flap
Military recruiting rebounds
To withdraw sickle cell drug
Settles defamation lawsuit
Capital goods orders up
Weekly jobless claims fall
Arrives in Luxembourg
Rose announces retirement
US economy grew
RU hits Ukraine's power grid
Jan. 6 report delayed
US suicides steady, high
Feedback